ID   EL-4-B5
AC   CVCL_5I39
SY   EL-4 B5; EL4-B5; EL4B5
DR   Kerafast; EVU301
DR   Wikidata; Q54832205
RX   PubMed=7691726;
CC   Characteristics: Can be used as a feeder layer to generate B cell cultures yielding human monoclonal antibodies (Kerafast=EVU301).
CC   Selected for resistance to: ChEBI; CHEBI_472552; 5-bromo-2'-deoxyuridine (Bromodeoxyuridine; BrdU; BUdR).
CC   Transformant: ChEBI; CHEBI_254496; 7,12-dimethyltetraphene (DMBA; dimethylbenzanthracene).
CC   Derived from site: In situ; Ascites; UBERON=UBERON_0007795.
CC   Cell type: T-cell; CL=CL_0000084.
CC   Breed/subspecies: C57BL/6N.
DI   NCIt; C21925; Mouse precursor T cell lymphoblastic lymphoma/leukemia
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_5680 ! EL4.BU.1.OUAr.1.1
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 14-12-15; Last updated: 19-12-24; Version: 12
//
RX   PubMed=7691726; PMCID=PMC1421996;
RA   Kwekkeboom J., de Boer M., Tager J.M., de Groot C.;
RT   "CD40 plays an essential role in the activation of human B cells by
RT   murine EL4B5 cells.";
RL   Immunology 79:439-444(1993).
//